(March 1, 2019) OCRA mourns the loss of our beloved board member and friend, Lori Newcomb. We are profoundly grateful for her vision and dedication in creating Newk’s Cares along with her loving husband, Chris, to support ovarian cancer research through their family business, Newk’s Eatery. Her unwavering and selfless commitment to help other women and to find a cure for this terrible disease is a testament to her incredible character. And her feisty, funny and infectious personality that shined so brightly will be sorely missed. Lori’s dedication and work to end ovarian cancer will live on through her legacy and will one day ensure that no other woman has to endure this terrible disease. Sending our love to Chris, Madison, Blair and Hayes.
Related Topics
Ovarian Cancer Research Alliance Launches Center for Public Policy to Strengthen National Voice for Ovarian and Gynecologic Cancers
New policy hub builds on record of helping to secure billions in federal funding and training thousands of advocates, with expanded priorities and an interactive policy map New York, NY – [November 20, 2025] — Ovarian Cancer Research Alliance (OCRA) today announced the launch of its Center for Public Policy, a dedicated hub that reflects expanded policy … Continued
OCRA Invests More than $10.8 Million Toward Research, Part of $14.5 Million Commitment in 2025
In 2025, Ovarian Cancer Research Alliance (OCRA) invested more than $10.8 million toward scientific research—part of our $14.5 million commitment to strengthen the community through research, patient support, education and advocacy. This year’s investment represents OCRA’s broadest scope to date, encompassing not only our renowned grant programs but also global collaborations leveraging artificial intelligence (AI) … Continued
The Overview: October 2025
KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued